Transplantation immunology encompasses the study of the immune responses that are elicited by the introduction of donor tissues or organs into a recipient. At its core, the field seeks to understand ...

The histocompatibility between donor and recipient in solid organ transplantation is essential to successful engraftment and longevity of the transplanted tissue. However, the limited organ ...

In this podcast episode, Professor Medhat Askar discusses the revolutionary changes in transplant immunology, focusing on his research and clinical practices related to organ and bone marrow ...

Results Support Further Evaluation of the Hemopurifier ® as Part of a Machine Perfusion Circuit to Further Assess its Impact on the Function of Retrieved Kidneys Aethlon Medical's Hemopurifier ® is a ...

Houston Methodist researchers identified a troublesome subset of T-cells in transplant recipients that may be a more effective therapeutic target for preventing transplant rejection in patients. Each ...

Discussing research results in the lab at the Houston Methodist Research Institute, Wenhao Chen, Ph.D., (right) and Xian C. Li, Ph.D., (left) have colla borated for many years. HOUSTON-(Mar. 14, 2024) ...

Associate Professor Department of Medicine Federico Simonetta obtained his medical degree from the University of Genoa in 2006. He then completed a Master's degree in basic immunology at the Pasteur ...

Please provide your email address to receive an email when new articles are posted on . Bruce Blazar, MD, will receive the E. Donnall Thomas Lecture and Prize at this year’s ASH Annual Meeting and ...

"Kidney transplantation provides the highest quality of life for those afflicted with end stage renal disease, yet there is a shortage of organs available, and for those who do receive organs, ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

Explore how pre-transplant treg therapy can enhance stem cell transplant safety and boost survival rates for blood cancer patients.